D-AP5, NMDA glutamate site antagonist
Be the first to review this product! Submit a review
|
(277 Publications)
- Proven performance: cited in over 270 publications
- Available in different sizes to fit your experimental needs
- Chemical Structure
Lab
Chemical Structure - D-AP5, NMDA glutamate site antagonist (AB120003)
2D chemical structure image of ab120003, D-AP5, NMDA glutamate site antagonist
- FuncS
PubMed
Functional Studies - D-AP5, NMDA glutamate site antagonist (AB120003)
Representative voltage-clamp recording (Vh= −60 mV, ECl−=+8 mV) of a Purkinje cells response to simulated ischemia and sequential block of glutamate receptors and GABAA receptors.
Image from Brady JD et al., Neuroscience. 2010;168(1):108-17. Fig 3.; doi: 10.1016/j.neuroscience.2010.03.009 with permission from Elsevier.
- FuncS
PubMed
Functional Studies - D-AP5, NMDA glutamate site antagonist (AB120003)
Averaged Ca2+ transients (500 Hz line scans) evoked by 40 ms voltage step in a dendrite (left) and spine (right) in control (black), D-AP5 (red, 10 µM), after a 10 min washout of D-AP5 (green), and in 5 µM NMDA (blue). Mibefradil (20 µM), nimodipine (20 µM) and TTX (0.5 µM) were present throughout.
Image from Herman MA et al., PLoS One. 2011;6(11):e26501. Fig 2(A).; doi: 10.1371/journal.pone.0026501. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/
- CellAct
Unknown
Cellular Activation - D-AP5, NMDA glutamate site antagonist (AB120003)
(A) Photomicrograph of a DCN fusiform cell filled with lucifer yellow (top) and whole cell voltage clamp recording of this fusiform cell while stimulating the LVN (bottom). (B) Photomicrograph of a DCN granule cell filled with lucifer yellow (top) and whole cell voltage clamp recording of this granule cell while stimulating the LVN (bottom). Both cells were held at -68 mV and the LVN was stimulated at 0.3 Hz. Glutamatergic EPSCs are represented in black and are blocked by 50 μm D-AP5 and 10 μm NBQX (traces in red). Each trace represents an average of 10-20 single traces. The arrowhead represents the artifact of stimulus that has been removed for clarity. Scale bar : (A) 50 μm, (B) 20 μm.
Image from Barker M et al., Plos One, 7(5), e35955. Fig 1,; doi: 10.1371/journal.pone.0035955
Product details
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Pathways
NMDARs and AMPA receptors integrate into key neural and signaling pathways such as the long-term potentiation pathway which is essential for memory formation. NMDAR activation allows calcium influx necessary for initiating intracellular signaling cascades. The interactions with proteins like CaMKII and synaptic scaffolds like PSD-95 illustrate the role of these receptors in synaptic and protein signaling networks that adjust synaptic strength.
Biological function summary
These glutamate receptor subunits forming part of NMDAR and AMPA receptor complexes modulate synaptic plasticity which underlies learning and memory. NMDARs are tetrameric complexes composed mostly of two GluN1 subunits combined with two region-specific GluN2 (A-D) or GluN3 (A B) subunits creating diversity in function and pharmacological characteristics. The AMPA receptor primarily built of GluA1 through GluA4 subunits contributes to fast excitatory neurotransmission. Together these receptors regulate calcium ion flow into neurons impacting cellular events essential for neural communication and adaptation.
Publications (277)
Recent publications for all applications. Explore the full list and refine your search
Communications biology 7:1707 PubMed39730868
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular brain 17:78 PubMed39511688
2024
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2410927 PubMed39435757
2024
Applications
Unspecified application
Species
Unspecified reactive species
Neurochemical research 49:2926-2939 PubMed39078522
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:110145 PubMed38952682
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:5095 PubMed38876987
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 44: PubMed38839301
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports methods 3:100544 PubMed37671014
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Methods & clinical development 30:1-13 PubMed37324975
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular neuroscience 16:1148219 PubMed37122623
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com